|
|
|
| home > ict > Autumn 2017 |
|
|
 PUBLICATIONS |
International Clinical Trials |
|
|
|
|
|
 |
| |
|
|
|
End Point
Cut Off
Dr Graham Hughes looks to the financial side of clinical trials, wondering how exactly Brexit might affect the pharma and healthcare industry's funding. |
|
|
|
Improving Site Activation
Three-Fold Solution
Sean Stanton at Bioclinica Research Network believes that proper leadership and oversight can protect site start-up from delays and complications caused by miscommunication between the large number of parties involved. |
|
|
Site Selection and Management
Important Choices
CIDP’s Bandana Seesurn acknowledges the difficulties in choosing a trial site, but also looks at the current resources simplifying this process, such as online platforms and other modern communication technology. |
|
|
|
eSource at the Sites
Revolutionary Potential
Mike Novotny and Nick O’Brien at Medrio discuss the difficulties
of getting site staff to adopt new
methods and technologies that
could eliminate paper practices
and provide excellent benefits.
|
|
|
Patient Consent Practices
Shredding Paper
DrugDev Patient Solutions' Eric Delente discusses the integration of eConsent methods into trials in place of out-dated paper consent forms, acknowledging patient empowerment and ease of understanding as key benefits.
|
|
|
Pharmacovigilance Online
Time to Listen
Caroline Legendre and Alexis Pinçon at UBC consider the integration of new technology into pharmacovigilance practices and how platforms offering unique opportunities to hear the collective voice of patients are growing in importance.
|
|
|
Clinical Trial Management Systems
The Connected CTMS
Utilisation of the cloud could reduce expenses and aid process efficiency, solving the problem of increased study complexity caused by the rising number of data sources, suggests Brion Regan at ERT.
|
|
|
|
Event Preview
Coming Together
In this introduction to PCT Europe 2017, we relay the topics that will be covered by experts on 28-29 November in RAI, Amsterdam. |
|
|
|
|
Japanese Clinical Research
Expert Knowledge
According to ICON’s Mary Pan, utilising CROs will overcome the hurdles that currently prevent Japan’s growth in the field of biopharmaceutical R&D.
|
|
|
|
|
Digital Developments
Through the Clouds
Focusing on the use of new technology in data management, Mike Capone at Medidata Solutions shows how machine learning methods have become crucial to production processes thanks to the availability of computing power. |
|
|
|
|
Site Nursing Support
Helping Hands
Improving standards of care is one of the pharma industry’s main goals, and it can lead to a rise in trial recruitment and retention rates. Helena Baker at Medical Research Network highlights how nurse visits are encouraging both.
|
|
|
|
|
Q&A: PCT Europe 2017
Teaming Up
Conference Director Louisa Maitland talks with ICT about the upcoming PCT Europe event, which will offer insight into industry issues.
|
|
|
|
|
Electronic Medical Records
On the Record
Full digital provision of the right patient health information could enable precision medicine to significantly improve disease treatment, and IT is key to enabling this, say Tigran Arzumanov and Le Vin Chin at Clinerion. |
|
|
Spotlight
elluminate® Mapper
This issue’s Spotlight feature is presented by eClinical Solutions, outlining innovations in data management tools that are allowing clinical development teams to become more self-sufficient.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center
Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020:
Italian-based Stevanato Group, a leading producer of glass primary
packaging and provider of integrated services for combination products,
and Nelson Laboratories, LLC, a global provider of lab testing and
expert advisory services signed today a partnership agreement that will
provide Extractables and Leachables testing at SG US Technology
Excellence Center in Boston, MA.
More info >> |
|
 |
White Papers |
 |
|
Overcoming research challenges with Adaptive Trials
PCI Pharma Services
There has been cause for concern within the pharmaceutical industry over
the last five years, regarding increasing research and development
costs, combined with a fall in the number of new drugs brought to
market. In an attempt to overcome this issue there has been a
significant rise in the use of adaptive clinical trial designs, whilst
saving time and money as well as facilitating more effective decision
making. One of the biggest challenges that pharmaceutical companies have
experienced has been delivering compliant clinical trials supplies
across diverse patient populations in the relatively short timeframes
that adaptive trial designs require, remaining focused on ensuring that
patient compliance and product quality is in no way compromised. This
demand has led to the launch of fast response services that support
Research and Development in responding to changing dosing regimens
mid-trial.
More info >> |
|
|
